ESSO Online Interactive Multidisciplinary Discussion on the Treatment Approaches for Invasive Lobular Carcinoma

02 June, 2022 - Closed

Venue: Online

Time: 6pm to 7.30pm CET


This webinar will be a live, interactive multidisciplinary team (MDT) discussion organized by the ESSO Educational Training Committee (Breast Working Group). Surgeons will obtain knowledge of the biology, diagnostics and different treatment strategies for invasive lobular breast cancer (ILC). This will also cover challenges and a multidisciplinary approach to imaging, surgery, and systemic treatments for pre- and post-menopausal women with ILC. The MDT will highlight patient perspectives on treatment decisions, future and ongoing clinical research for ILC.

Main Topics

  • Incidence, etiology and risk factors
  • How ILC differs from ductal cancers, histology, pathology, subtypes of ILC
  • MRI- role in the assessment of ILC
  • Indications for and value of PET-scan in ILC
  • The role of endocrine therapy and chemotherapy in treating ILC
  • Unique challenges for the MDT in treating ILC 
  • Patient perspectives
  • Future perspectives and ongoing research


Carmela Caballero, Breast International Group (BIG), Brussels, BE
José Volders, Diakonessenhuis, Utrecht, NL


Giuseppe Viale - Pathologist (University of Milan, Milan, IT)
Marie-Jeanne Vrancken Peeters - Surgeon (Netherlands Cancer Institute, Amsterdam, NL)
Christos Sotiriou - Oncologist (Jules Bordet Institute, Brussels, BE)
Panagiotis Kapetas - Radiologist (Medical University of Vienna, AT)
Christine Desmedt - Scientist (KU Leuven, BE)
Ines Nevelsteen - Surgical Oncologist (KU Leuven, BE)

Target participants

  • Breast surgeons
  • Any health professional involved or interested in the treatment of invasive lobular carcinoma

Registration fees

  • 25€ for ESSO members
  • 30€ for non-members


An application for CME accreditation has been submitted to the ACOE (Accreditation Council of Oncology in Europe)

This course is closed